Dr. Robert Califf has been nominated for the position of Commissioner of Food and Drugs. He is praised for his expertise in clinical trial research, health disparities, healthcare quality, and cardiovascular medicine. Previously serving as FDA Commissioner from 2016-2017, he received strong bipartisan support in the Senate. Dr. Califf's experience and leadership are seen as crucial in guiding the FDA during the COVID-19 pandemic, particularly in making important decisions regarding vaccine approvals. His confirmation is urged to ensure the FDA continues to make science and data-driven decisions. Currently, Dr. Califf is a professor of medicine at Duke University School of Medicine and holds positions at Verily Life Sciences. He has led numerous significant clinical trials and is widely published in biomedical science.